MikhailRoshalMD

PubMed

• Flow cytometry evaluation of acute myeloid leukemia minimal residual disease based on an understanding of the normal maturation patterns in the blast compartments.
  Mikhail Roshal, Qi Gao
  American Journal of Clinical Pathology. 2025-02-08
• Deep immunophenotypic dissection and clinical impact of T cells in the follicular lymphoma microenvironment.
  Sary El Daker, David Qualls, Andriy Derkach, Samida Beqaj, Leonardo Boiocchi
  Haematologica. 2025-02-06
• Polytypic B cells, monotypic/monoclonal B-cell proliferations, and neoplastic T cells diverge from-/-mutant clonal hematopoiesis in follicular helper T-cell lymphomas.
  Natasha E Lewis, Kseniya Petrova-Drus, Rohan Sardana, Sarah Huet, Qi Gao
  Haematologica. 2025-02-01

Journal Articles

• Acquired Resistance to IDH Inhibition Through Trans or Cis Dimer-Interface Mutations  
  Martin S Tallman, Eytan M Stein, Alan H Shih, Maria E Arcila, Andrew M Intlekofer, Craig B Thompson, Mikhail Roshal, Nature

Abstracts/Posters

• Acute Leukemia with Lineage Infidelity: Mixed Phenotype AML Exhibits a Distinct Immunophenotype with Clinical Features Overlapping Mixed Phenotype Acute Leukemia
  Mikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...
  Mikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a Spike-in Clonal Sequence
  Mikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Bone Marrow Morphologic Findings in Patients Receiving IDH Inhibitor Therapy in Combination with Intensive Induction Chemotherapy: Challenges with Interpretation of th...
  Mikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Comparison of MALDI-TOF Mass Spectrometry Analysis of Peripheral Blood and Bone Marrow Based Flow Cytometry for Tracking Measurable Residual Disease (MRD) in Patients ...
  Mikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Weekly Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab (wKRd-D) Combination Therapy Provides Unprecedented MRD Negativity Rates in Newly Diagnosed Multiple My...
  Mikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...
  Mikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• CD4 Lymphocytes and T Regulatory Cells Show Distinct Phenotypes in Follicular Lymphoma and Classical Hodgkin Lymphoma Which May Account for Differences in Responses to...
  Mikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Annotation of Somatic Genomic Variants in Hematologic Diseases Using OncoKB, a Precision Oncology Knowledgebase
  Mikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• RNA Sequencing of Hodgkin Lymphoma Reed-Sternberg Cells Uncovers a Plasma Cell Signature and Escape from NK Cell Recognition
  Mikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Evaluation of Tagraxofusp (SL-401) Alone and in Combination with Ruxolitinib for the Treatment of Myeloproliferative Neoplasms
  Mikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Aberrant SYK Expression As a Potential Therapeutic Target in T/NK Cell Neoplasms
  Mikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• MRD-Response Driven Phase I/II Study for Newly Diagnosed Multiple Myeloma Patients Using Higher Doses of Twice-Weekly Carfilzomib (45 and 56 mg/m2) in Combination with... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Circulating Lymphoma Cells in Mycosis Fungoides/Sezary Syndrome Show Heterogeneity of the Cell-of-Origin and Variable PD-1 Expression By Flow Cytometric Analysis 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018